What is Quiver Bioscience?
Quiver Bioscience is a pioneering technology-driven entity focused on creating breakthrough medicines for the brain. The company is dedicated to uncovering new biological insights and identifying novel, effective drug targets. By leveraging advanced single-cell imaging and multi-omics technologies, Quiver Bioscience is constructing the world's most comprehensive neuronal insight map, termed the "Genomic Positioning System." Their integrated methodology combines scalable human models, cutting-edge technology, proprietary engineering, and sophisticated AI/ML models to pinpoint new therapeutic targets and optimal candidate molecules for delivering impactful treatments to patients.
How much funding has Quiver Bioscience raised?
Quiver Bioscience has raised a total of $2M across 1 funding round:
Grant
$2M
Grant (2025): $2M with participation from National Institutes of Health (NIH
Key Investors in Quiver Bioscience
National Institutes of Health (NIH
The National Institutes of Health (NIH), a leading agency for biomedical research, provides foundational support for scientific advancement in health and medicine.
What's next for Quiver Bioscience?
With substantial enterprise-level backing, Quiver Bioscience is poised for accelerated growth and the advancement of its therapeutic pipeline. The company's focus on integrating advanced imaging, multi-omics, and AI/ML suggests a strategic direction towards rapid target identification and drug candidate validation. This significant capital infusion will likely fuel further research and development, clinical trial progression, and the scaling of their proprietary "Genomic Positioning System" to solidify their position in the competitive neuro-therapeutics landscape.
See full Quiver Bioscience company page
